BML Capital Management, LLC

Position in ORMP — Oramed Pharmaceuticals Inc.

CIK 1616824 ZIONSVILLE, IN

Position in ORMP

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$4,166,753

-$6,601,832 QoQ

Shares Held

866,269

-72.6% QoQ

Ownership

2.08%

of shares outstanding

% of Portfolio

2.38%

of 13F equity value

Holder Rank

of 84 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

BML Capital Management, LLC holds $130,180,167 across 10 Biotechnology names. ORMP ranks #6 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACRS	Aclaris Therapeutics, Inc.	11,975,000	$63,347,750
2	AVIR	Atea Pharmaceuticals, Inc.	6,952,330	$32,328,334
3	ENGN	enGene Therapeutics Inc.	6,669,908	$11,538,940
4	PMVP	PMV Pharmaceuticals, Inc.	5,330,000	$7,142,200
5	TIL	Instil Bio, Inc.	645,600	$4,964,664
6	ORMP	Oramed Pharmaceuticals Inc. This page	866,269	$4,166,753
7	JANX	Janux Therapeutics, Inc.	154,961	$2,380,200
8	PLRX	Pliant Therapeutics, Inc.	1,546,137	$1,762,596

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,166,753	866,269	-72.6%	Shares	Sole	2026-08-07
2026-03-31	$10,768,585	3,167,231	0.0%	Shares	Sole	2026-05-06
2025-12-31	$9,026,608	3,167,231	0.0%	Shares	Sole	2026-02-03
2025-09-30	$8,361,489	3,167,231	+2.7%	Shares	Sole	2025-11-10
2025-06-30	$6,937,319	3,083,253	+2.1%	Shares	Sole	2025-08-11
2025-03-31	$6,464,400	3,020,748	+14.3%	Shares	Sole	2025-05-07
2024-12-31	$6,398,254	2,643,907	+20.9%	Shares	Sole	2025-02-07
2024-09-30	$5,334,306	2,186,191	+62.1%	Shares	Sole	2024-11-05
2024-06-30	$3,467,027	1,349,038	+72.7%	Shares	Sole	2024-08-07
2023-09-30	$2,039,172	781,292	-8.1%	Shares	Sole	2023-10-23
2023-06-30	$3,043,000	850,000	-37.3%	Shares	Sole	2023-07-24
2023-03-31	$2,955,916	1,355,925	—	Shares	Sole	2023-04-14
No filing history on record for this holder in this stock.